Xia YY

No ORCID on file · 3 papers in corpus
2022
Hereditary cancer in clinical practice ·doi:10.1186/s13053-022-00227-z

BRCA1 and BRCA2 mutation carriers face an elevated lifetime risk of developing ovarian cancer. Oral contraceptives have been shown to significantly decrease the risk of ovarian cancer by approximately 50% in this high-risk population. Chang…

2015
Cancer biomarkers : section A of Disease markers ·doi:10.3233/cbm-150534

BackgroundGastric cancer is the fourth most frequent cancer and the second cause of cancer-related deaths worldwide. China has a high incidence of gastric cancer. Inflammation is a critical component of tumor progression. It has been widely…

2012
PloS one ·doi:10.1371/journal.pone.0045364

BackgroundThe DNA demethylating agent 5-aza-2'-deoxycytidine (5-aza-CdR) incorporates into DNA and decreases DNA methylation, sparking interest in its use as a potential therapeutic agent. We aimed to determine the effects of maternal 5-aza…